Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy.
South Asian J Cancer
; 6(1): 1-5, 2017.
Article
em En
| MEDLINE
| ID: mdl-28413785
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
Idioma:
En
Revista:
South Asian J Cancer
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Índia